Pradeep Bajad

Assistant Professor, Pulmonary Medicine, Amrita Hospital & School of Medicine, Delhi NCR

[Pradeep Bajad @Pradeepbajad_7]

Choose health, not smoke. Today is #WorldNoTobaccoDay, the perfect day to quit, reset, and reclaim your lungs. Your future is in your hand.
#COPD #LungCancer

[Pradeep Bajad @Pradeepbajad_7]

@bhavinj Here comes the role of regular, frequent follow-up of TB effusion cases with imaging. Barely 2-3 X-rays are done during management. Timely picking up of non-expanding lung, thickened pleura, and intervention in the form of adding steroids and timely decortication can help.

[Pradeep Bajad @Pradeepbajad_7]

Era of unnecessary medical testing behavior.
#bloodtest #Vitamin

[Bhavin Jankharia @bhavinj]

Today's full-page Times of India ad wants you to test your Vitamin D for tiredness, cramps, low mood.

The USPSTF explicitly does NOT recommend routine Vitamin D testing in healthy people.

The "deficiency" is largely a cut-off shifted from 20 to 30 ng/ml — turning normal people into "insufficient" overnight.

https://t.co/ikgJunyFTL

[Pradeep Bajad @Pradeepbajad_7]

MiniDock test shows promising results in detecting tuberculosis, even in saliva! #MiniDock #Tuberculosis

[NEJM @NEJM]

Original Article: Pulmonary Tuberculosis Detection with MiniDock MTB Using Swab Samples https://t.co/dJzhkDy7Ei #InfectiousDisease #GlobalHealth

[Pradeep Bajad @Pradeepbajad_7]

@ERSpublications Big fan of TMC. Gives enough tissues for HPE, IHC & molecular studies.

[Pradeep Bajad @Pradeepbajad_7]

A biomarker-guided approach for treating asthma attacks, focusing on how to pick the best medication, such as corticosteroids or biologics, while also considering underlying infections.
#ChestJournal #Asthma

[CHEST® Journal @journal_CHEST]

A CHEST Review explores asthma exacerbation heterogeneity and discusses current and emerging management strategies, including precision medicine in acute asthma.

Read more in the April issue of the journal CHEST®: https://t.co/q5hvavGkVD
#MedEd #JournalCHEST #Asthma

[Bhavin Jankharia @bhavinj]

Jellyfish sign 🪼
44M. 15 mm RML nodule. Biopsy → adenocarcinoma.
3 tags to costal pleura (green) + more tags to major fissure (red).
Tags to >1 pleural surface = visceral pleural invasion until proven otherwise.
Full case: https://t.co/FddZNDDAj2
#ctchest #lungcancer

[James D Chalmers @ProfJDChalmers]

Both 10mg and 25mg brensocatib has been approved in the US for treatment of bronchiectasis.
In the absence of official guidance, Chuck Daley and i comment on optimal dosing, concluding that 25mg should be the preferred dose for patients
@ATSBlueEditor
https://t.co/qrSUlAh7R9

[Pradeep Bajad @Pradeepbajad_7]

Bronchiectasis algorithm.
#ERS #Bronchiectasis

[James D Chalmers @ProfJDChalmers]

The New @EuroRespSoc Bronchiectasis Guidelines explained with clinical scenarios, case studies and algorithms.
Just published in Breathe: A Clinical Summary to the ERS Bronchiectasis Guidelines
@OSibila @MereteLong @Beika_Physio @AlibertiStefano
https://t.co/C5boUJjBIy

[Pradeep Bajad @Pradeepbajad_7]

@ProfJDChalmers Audience will equally love your dance too

[Pradeep Bajad @Pradeepbajad_7]

New evidence supports the role of low-dose apixaban (2.5 mg BID) in preventing recurrent VTE even after a provoked event with low bleeding risk and better adherence than warfarin.

Key update: Don’t stop at 3 months without reassessing recurrence risk.
#NEJM #VTE

[NEJM @NEJM]

In patients with provoked venous thromboembolism and ongoing risk factors, extended treatment with low-dose apixaban for 12 months resulted in a lower risk of recurrent VTE than placebo, with a low risk of major bleeding. Full HI-PRO trial results and Research Summary: https://t.co/Ow5OfV9KxI

[Pradeep Bajad @Pradeepbajad_7]

New EULAR/ERS Guidelines for CTD-ILD management.
This update is focussed on screening, risk factors, immunomodulators and antifibrotics.
#Rheumatology @eular_org @ERSpublications #ILD
Antoniou KM, et al. ERS/EULAR clinical practice guidelines for ctd-associated ILD. ERJ 2025.

[Pradeep Bajad @Pradeepbajad_7]

First ever drug for bronchiectasis approved! The FDA has approved Brensocatib — a milestone in respiratory medicine and a new hope for patients with non-CF bronchiectasis.
#Bronchiectasis #Pulmonology #Brensocatib

[James D Chalmers @ProfJDChalmers]

We did it! The first approved medication for bronchiectasis
Brensocatib approved by the FDA in the United States. A great day for patients and the scientific community that made this happen. Thank you Insmed, all investigators and participants
https://t.co/T5XthQtIRI

[Pradeep Bajad @Pradeepbajad_7]

WABIP releases recommendations on airway stenting for benign central airway obstruction.
A must-read for all interventional pulmonologists.
#Bronchoscopy #Airwaystent #InterventionalPulmonology

[Pradeep Bajad @Pradeepbajad_7]

New insights on fibrotic HP patterns on CT: In 164 patients with typical fibrotic HP CT pattern: 22% diagnosed with CTD-ILD on MDD, Additional 14% developed autoimmune serologies or CTD on follow-up.
https://t.co/r4NssiDUu1
@ATSBlueEditor #HP_ILD

[Pradeep Bajad @Pradeepbajad_7]

Green Earth, Clean Earth—Our Responsibility. #Greenearth #Cleanair

[Amrita Hospital, Faridabad @amritafbd]

Every breath we take is a reminder of our connection with nature.
This World Environment Day, let’s protect the air we breathe and the planet we live in.

At Amrita Hospital Faridabad, we believe that healing begins not just in hospitals, but in the environment around us.

[Pradeep Bajad @Pradeepbajad_7]

New BTS Guidelines on Aspergillus Lung Disease 🦠
Essential update for Pulmonologists.
Check it out 👇
https://t.co/DuaoAOTI0w

#BTS #Aspergillus

[Pradeep Bajad @Pradeepbajad_7]

New head-to-head trial shows greater weight reduction with Tirzepatide (-20.2%) compared to Semaglutide (-13.7%).
Game changer in the fight against obesity?

#ObesityTreatment #WeightLoss #NEJM #Endocrinology #ObesityCare

[NEJM Clinician @NEJMClinician]

Tirzepatide vs. Semaglutide for Patients with Obesity: A Head-to-Head Trial https://t.co/epTp2K8gyw

@NEJM #semaglutide #tirzepatide #obesity

[Pradeep Bajad @Pradeepbajad_7]

We are glad to share that Department of Pulmonary medicine, Amrita school of medicine and hospital is pleased to announce the commencement of 1 year fellowship in Interventional Pulmonology and Pulmonary critical care. Candidates will be selected after a theory exam and viva.

[Pradeep Bajad @Pradeepbajad_7]

Got an opportunity to attend the annual Japanese Respiratory Society Meeting #JRS to present my research paper.
Thank you JRS & #APSRapsr for the opportunity.